BAO PHARMA-B(02659.HK) closed 9.16% higher, closing at HKD 27.4
- Hong Kong Recently Listed Stocks Daily Report: METALIGHT Rises 32.27% to Lead, Computing Power Chip Theme Heats Up-20261116
- Hong Kong Recently Listed Stocks Daily Report: INNOGEN-B Tops Gainers with 17.68% Rise as Interest in Pharmaceuticals and Solar Returns-20261105
- BAO PHARMA-B (02659.HK): NMPA Approves IND Application for BJ045 Injection
- BAO PHARMA-B (02659.HK): IND for KJ015 injection (anti-HER2 bispecific antibody subcutaneous formulation) approved by US FDA
- BAO PHARMA-B(02659.HK): Subcutaneous Infusion Ceftriaxone Sodium BJ007 FDA IND Approval